SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000904454-16-000898
Filing Date
2016-01-27
Accepted
2016-01-27 16:17:08
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO SCHEDULE 13G FOR SAGENT PHARMACEUTICALS, INC. BY VIVO VENTURE s13ga_012716-sagent.htm SC 13G/A 251916
  Complete submission text file 0000904454-16-000898.txt   253560
Mailing Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195
Business Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195 847-908-1604
Sagent Pharmaceuticals, Inc. (Subject) CIK: 0001369786 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13G/A | Act: 34 | File No.: 005-86638 | Film No.: 161365225
SIC: 2834 Pharmaceutical Preparations

Mailing Address 575 HIGH STREET, SUITE 201 PALO ALTO CA 94301
Business Address 575 HIGH STREET, SUITE 201 PALO ALTO CA 94301 650-688-0818
Vivo Ventures V, LLC (Filed by) CIK: 0001399028 (see all company filings)

IRS No.: 841663511 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A